These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 26652899)
1. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Kiluk BD; Carroll KM; Duhig A; Falk DE; Kampman K; Lai S; Litten RZ; McCann DJ; Montoya ID; Preston KL; Skolnick P; Weisner C; Woody G; Chandler R; Detke MJ; Dunn K; Dworkin RH; Fertig J; Gewandter J; Moeller FG; Ramey T; Ryan M; Silverman K; Strain EC Drug Alcohol Depend; 2016 Jan; 158():1-7. PubMed ID: 26652899 [TBL] [Abstract][Full Text] [Related]
2. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960 [TBL] [Abstract][Full Text] [Related]
3. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials. Amin-Esmaeili M; Farokhnia M; Susukida R; Leggio L; Johnson RM; Crum RM; Mojtabai R Addiction; 2024 May; 119(5):833-843. PubMed ID: 38197836 [TBL] [Abstract][Full Text] [Related]
4. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864 [TBL] [Abstract][Full Text] [Related]
5. Evaluating Patient-Centered Outcomes in Clinical Trials of Procedural Sedation, Part 1 Efficacy: Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research Recommendations. Williams MR; Ward DS; Carlson D; Cravero J; Dexter F; Lightdale JR; Mason KP; Miner J; Vargo JJ; Berkenbosch JW; Clark RM; Constant I; Dionne R; Dworkin RH; Gozal D; Grayzel D; Irwin MG; Lerman J; O'Connor RE; Pandharipande P; Rappaport BA; Riker RR; Tobin JR; Turk DC; Twersky RS; Sessler DI Anesth Analg; 2017 Mar; 124(3):821-830. PubMed ID: 27622720 [TBL] [Abstract][Full Text] [Related]
6. Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research. Stoops WW; Rush CR Expert Rev Clin Pharmacol; 2014 May; 7(3):363-74. PubMed ID: 24716825 [TBL] [Abstract][Full Text] [Related]
7. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Angelo FN; McDonell MG; Lewin MR; Srebnik D; Lowe J; Roll J; Ries R Drug Alcohol Depend; 2013 Jul; 131(1-2):162-5. PubMed ID: 23273776 [TBL] [Abstract][Full Text] [Related]
8. Validating the clinical relevance of alternative stimulant use treatment outcome measures by examining their association with 3-month follow-up outcomes. Miguel AQC; Smith CL; Burduli E; Roll JM; McPherson SM Exp Clin Psychopharmacol; 2021 Jun; 29(3):288-293. PubMed ID: 34264739 [TBL] [Abstract][Full Text] [Related]
9. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers. Camacho A; Akiskal HS J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692 [TBL] [Abstract][Full Text] [Related]
10. Predictors and Outcomes of Twelve-Step Sponsorship of Stimulant Users: Secondary Analyses of a Multisite Randomized Clinical Trial. Wendt DC; Hallgren KA; Daley DC; Donovan DM J Stud Alcohol Drugs; 2017 Mar; 78(2):287-295. PubMed ID: 28317510 [TBL] [Abstract][Full Text] [Related]
11. What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning? Kiluk BD; Fitzmaurice GM; Strain EC; Weiss RD Addiction; 2019 Jan; 114(1):9-15. PubMed ID: 29900624 [TBL] [Abstract][Full Text] [Related]
12. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. Chartier KG; Sanchez K; Killeen TK; Burrow A; Carmody T; Greer TL; Trivedi MH Am J Addict; 2015 Jun; 24(4):336-40. PubMed ID: 25694201 [TBL] [Abstract][Full Text] [Related]